On this page
Key takeaways
- Take fisetin with a fat-containing meal. Fisetin is fat-soluble; the only published human PK study administered it fasted and reported very low plasma levels (1).
- Morning is the sensible default — for both continuous daily dosing and the pulsed protocol. Aligns with the Mayo Clinic administration schedule and makes any mild sedation manageable during the day.
- Do not split the pulsed dose across the day. The senolytic aim is a high plasma peak, not sustained low exposure (2).
- Continuous daily dosing has independent flavonoid-antioxidant rationale but is not the senolytic protocol. See our dedicated pulse dosing article for the trial-aligned schedule.
- Fisetin can generally be co-administered with other longevity supplements (NMN, spermidine, urolithin A) with no known pharmacokinetic conflicts, but formal interaction studies are absent.
- Cycling is optional for continuous daily protocols and mandatory for the pulsed protocol — the 28-day off period between pulses is the biological premise, not a break.
Quick answer
Take fisetin with a fat-containing meal, ideally in the morning. If you are taking a daily capsule, one dose with breakfast is the simplest evidence-adjacent approach. If you are following the trial-aligned pulsed protocol, take the entire day’s dose in a single sitting with a fatty meal on day 1, do the same on day 2, then stop for 28 days. Fisetin can be co-administered with most other longevity supplements. It should not be taken during pregnancy or breastfeeding without obstetric consultation. For the full clinical context, see our complete clinician’s guide.
Take fisetin with fat
This is the single practical intervention with the strongest evidence base for improving unformulated capsule absorption.
Fisetin is highly lipophilic — poorly water-soluble, well-soluble in oils and fats. Absorption from the intestinal lumen depends on solubilisation in bile-acid micelles, which requires dietary fat as a mixing partner. The Krishnakumar 2022 human pharmacokinetic study administered fisetin in the fasted state and reported a peak plasma concentration of just 9.97 ng/ml after a 1,000 mg dose — well below the concentrations that produce senolytic effects in cell culture (1). The study did not directly test fed-versus-fasted absorption, but general flavonoid pharmacokinetic principles — well established for quercetin, curcumin, and similar polyphenols (5) — strongly predict that co-ingestion with fat improves absorption meaningfully.
Practical translations: take fisetin with a meal containing at least 10 to 15 grams of fat. Olive oil, avocado, nuts, whole eggs, full-fat dairy, or fatty fish all work. A green tea and dry toast breakfast is not enough fat context for a fat-soluble compound. If your usual breakfast is low-fat, this is worth adjusting for the days you take fisetin — a small addition of olive oil, tahini, avocado, or a handful of walnuts is sufficient. Our dedicated bioavailability article walks through the pharmacokinetic detail behind the fat co-ingestion recommendation.
Time of day: morning is the sensible default
No human trial has directly compared morning versus evening fisetin dosing for either efficacy or tolerability. The morning default is a recommendation from three converging considerations.
1. The trial protocols administer in the morning
The Mayo Clinic pulsed protocols administer fisetin in the morning with breakfast — this is the trial-day standard for adult participants at Rochester Methodist Hospital (3,4). It matches breakfast-associated fat intake and clinical monitoring schedules.
2. Any mild sedative effect is easier to manage during the day
A subset of anecdotal reports describe mild fatigue or sedation after fisetin — mechanistically consistent with flavonoid activity on GABAergic pathways. If you experience this effect, morning dosing lets it dissipate over the day. Evening dosing risks having the effect overlap with sleep architecture, which is unstudied and potentially unhelpful.
3. Interference with sleep architecture is theoretically possible
Fisetin’s antioxidant activity in the brain could plausibly interact with the redox signalling that regulates circadian rhythm. This is speculative — no human trial has measured it — but the theoretical case leans toward morning administration until data emerge.
If morning does not suit you practically, lunchtime with a fat-containing midday meal is the second-best option. Late-evening dosing with dinner is defensible but has no evidence advantage.
Continuous daily dosing versus pulsed protocol
The single largest editorial fact about fisetin timing is not what time of day you take it — it is whether you take it every day or in short pulses. These are structurally different protocols with different scientific rationales.
Continuous daily dosing (typical commercial format)
100 to 500 mg per capsule, taken once daily with a fat-containing meal, indefinitely. This is the format of the vast majority of commercial fisetin products. It matches no published human efficacy protocol for senolytic activity. It is a defensible dietary flavonoid supplementation approach: fisetin at 500 mg per day is a substantial supplemental dose of a well-characterised flavonoid antioxidant, and general dietary polyphenol supplementation has independent evidence for cardiovascular and cognitive endpoints. But it should not be marketed or interpreted as "the senolytic dose." It is not.
Pulsed protocol (trial-validated format)
20 mg/kg for two consecutive days, then no fisetin for 28 days, cycled monthly. This is the format used in every published human trial of fisetin as a senolytic (3,4). For a 70 kg adult it corresponds to approximately 1,400 mg on day 1, 1,400 mg on day 2, then a 28-day off period before repeating. Approximately 12 pulses per year. The biological rationale — the hit-and-run mechanism of senescent cell clearance — is covered in detail in our pulse dosing article.
Readers with commercial capsule products can align with the trial protocol by taking 3 to 4 capsules of a typical 500 mg product on day 1, the same amount on day 2, then stopping for 28 days. This uses the same product in the trial-aligned pattern rather than the daily-continuous pattern.
Splitting the dose — should you?
No. For pulsed dosing, take the entire daily dose in a single sitting.
The senolytic mechanism depends on reaching a threshold concentration of fisetin in tissue — the senolytic window of roughly 1 to 5 μM in cell culture. Above this threshold, senescent cells are selectively killed; below it, they are not. Splitting the dose across the day produces two smaller plasma peaks rather than one large one, reducing the maximum tissue concentration achieved. Because fisetin has a short plasma half-life (approximately two hours) and does not accumulate meaningfully over 24 hours, split dosing lowers the peak without extending the duration above threshold.
For continuous daily dosing, the argument is weaker — daily antioxidant supplementation is not a peak-driven pharmacology — but even so, a single once-daily dose with breakfast is administratively simpler than split dosing and has no clear disadvantage. If you are taking 500 mg per day as a daily flavonoid, take it once with breakfast rather than as 250 mg twice.
Fisetin with other supplements — the stacking question
Fisetin is often taken as part of a broader longevity supplement stack. No published human trial has tested any specific combination, but the pharmacology of the individual components allows some general guidance.
Fisetin plus quercetin
Both are flavonols. They target overlapping SCAPs (senescent cell anti-apoptotic pathways) (7). In cell culture, some fisetin-quercetin combinations show additive senolytic activity. Practically, they can be taken together with the same meal. No pharmacokinetic conflict is expected. Our fisetin vs quercetin article covers both the comparison and the combination case.
Fisetin plus NMN
Different mechanisms — fisetin clears senescent cells; NMN replenishes NAD⁺ substrate for sirtuin and PARP activity. They can be taken together at the same meal. No interaction has been characterised in human data. Some practitioners stagger by taking NMN in the morning and fisetin later in the day, but there is no evidence advantage to staggering.
Fisetin plus spermidine
Different mechanisms — fisetin is a senolytic; spermidine induces autophagy. They can be co-administered. Both are fat-soluble and both benefit from co-ingestion with a fatty meal. Our fisetin vs spermidine article covers the pharmacology and the case for combination.
Fisetin plus urolithin A
Fisetin is senolytic; urolithin A induces mitophagy. Distinct mechanisms, both flavonoid-family compounds, no known interaction. Our fisetin vs urolithin A article compares the evidence bases.
Fisetin plus prescription medications
This is where caution applies. Fisetin is a CYP2C8 substrate and a mild inhibitor of several other cytochrome P450 enzymes in vitro. Interactions with warfarin, direct oral anticoagulants, antiplatelet agents, tyrosine kinase inhibitors, and CYP2C8-metabolised drugs are theoretically possible. Our drug interactions article walks through the specific medication classes. If you are on any prescription medication, clear fisetin with your prescriber before starting.
Cycling — when off periods matter
For the pulsed protocol, the 28-day off period between pulses is not optional — it is the biological premise. Senescent cells regenerate slowly; the off cycle is when the tissue benefits accrue and when off-target concerns dissipate. Cycling is the whole point of the pulsed approach.
For continuous daily dosing, formal cycling has no evidence base. Some practitioners recommend one week off every three months as a general precaution. There is no clinical trial that supports this pattern. If you are taking a low-dose daily supplement for its flavonoid antioxidant effects, running continuously without breaks is not clearly worse than periodic breaks.
How long before I feel anything?
Honestly, in most cases: never — at least not in the way you would feel caffeine or magnesium. Fisetin’s proposed mechanism is slow tissue-level senescent-cell clearance and modest antioxidant activity. Subjective improvements in energy, focus, or sleep within days of starting are not consistent with the pharmacology. If you experience marked subjective changes early, the most likely explanations are placebo response or the broader flavonoid effects (mood, GI tone) common to polyphenol supplementation.
If you want to track anything objectively, hs-CRP (inflammatory marker) before and after a defined trial window (typically 3 to 6 months) is the closest available surrogate to what the trials are measuring. Grip strength and gait speed are the endpoints AFFIRM and PROFFi are tracking for muscle-preservation effects. Subjective cognitive tests are unreliable as personal endpoints — placebo effects are large.
What we still don't know
- Whether morning dosing is actually better than evening dosing. No trial has directly compared timing. The morning default is a translational recommendation, not a data-driven one.
- Whether specific fat sources improve absorption differentially. MCT oil, olive oil, avocado, and whole-food fat sources have not been directly compared for fisetin absorption in humans.
- Whether specific supplement combinations (fisetin + quercetin, fisetin + NMN) are meaningfully synergistic or antagonistic in humans. No clinical trial has tested any combination.
- Whether the timing of the pulsed protocol relative to menstrual cycle, meal timing, or exercise affects senolytic efficacy. All ongoing trials use fixed calendar-day dosing without adjustment for these variables.
Bottom line
Take fisetin with a fat-containing meal, ideally in the morning. If you are on continuous daily dosing, one 100–500 mg capsule with breakfast is the simplest evidence-adjacent format. If you are aligning with the trial-validated pulsed protocol, take 20 mg/kg in a single morning dose on day 1 and again on day 2, with fatty meals, then stop for 28 days. Do not split the pulsed dose across the day. Co-administration with other longevity supplements (NMN, spermidine, urolithin A, quercetin) is broadly safe in the absence of specific interaction data. Cycling is mandatory for the pulsed protocol and optional for daily dosing. For evidence tier context, see our full clinician’s guide. For the dose numbers, see our dosage article.
Frequently asked questions
Should I take fisetin on an empty stomach?
No. Fisetin is fat-soluble and absorbs poorly without dietary fat. The single human PK study measured very low plasma levels after a fasted 1,000 mg dose (1). Take with a fat-containing meal.
Can I take fisetin at night?
You can. But the trial protocols use morning administration, and the theoretical concerns about sleep architecture and fatigue side effects favour morning. There is no direct comparative evidence.
Should I take fisetin every day or in pulses?
The senolytic biology and every published human trial argue for pulses (20 mg/kg × 2 days, every 28 days). Daily dosing is a defensible dietary flavonoid approach but is not the senolytic protocol. Our pulse dosing article covers the schedule in detail.
Can I take fisetin with coffee?
Yes. Coffee does not interfere with fisetin absorption. Some readers add MCT oil or full-fat cream to coffee, which provides the fat co-ingestion recommended for fisetin absorption. Green tea catechins may compete with flavonol absorption at very high tea intakes, but ordinary coffee or a cup of tea alongside a fatty breakfast poses no meaningful problem.
How long does fisetin take to kick in?
Subjectively, in most cases, it doesn’t kick in at all. The proposed mechanisms are slow tissue-level processes. Any endpoint likely to move (inflammatory markers, muscle function) takes weeks to months. Fisetin is not a felt supplement.
Can I combine fisetin with quercetin?
Yes. Both are flavonols with overlapping mechanisms; co-administration is common in longevity practice. Our fisetin vs quercetin article covers the combination case.
References
- Krishnakumar IM, Jaja-Chimedza A, Joseph A, et al. Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study. J Nutr Sci. 2022;11:e74. https://doi.org/10.1017/jns.2022.72
- Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28. https://pmc.ncbi.nlm.nih.gov/articles/PMC6197652/
- AFFIRM: Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (NCT03430037). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT03430037
- Verdoorn BP, Evans TK, Hanson GJ, et al. Fisetin for COVID-19 in skilled nursing facilities: senolytic trials in the COVID era. J Am Geriatr Soc. 2021;69(11):3023-3033. https://pmc.ncbi.nlm.nih.gov/articles/PMC8447437/
- Lotito SB, Zhang WJ, Yang CS, et al. Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties. Free Radic Biol Med. 2011;51(2):454-463. https://pubmed.ncbi.nlm.nih.gov/21571060/
- Sasaki M, Yasushi Y, Ohgomori T, et al. Fisetin promotes hair growth by augmenting TERT expression. Front Cell Dev Biol. 2020;8:566617. https://pmc.ncbi.nlm.nih.gov/articles/PMC7593534/
- Elsallabi O, Patruno A, Pesce M, et al. Fisetin as a senotherapeutic agent: biopharmaceutical properties and crosstalk between cell senescence and neuroprotection. Molecules. 2022;27(3):738. https://pmc.ncbi.nlm.nih.gov/articles/PMC8838024/